Consensus on How to Conduct Follow-Up in Peripheral Vascular Disease

Peripheral vascular disease involves multiple areas and, therefore, can have very different presentations (from complete lack of symptoms to disabling symptoms). Depending on clinical presentation, general condition, anatomical localization, and lesion extension, revascularization can be indicated alongside optimal medical treatment.

Seguridad de los balones con paclitaxel en enfermedad vascular periférica

In 2017, guidelines with indications for revascularization were published; however, maintaining long-term patency can be challenging regardless of the strategy.

The rationale for follow-up is to optimize strategies to reduce the number of cardiovascular events, reduce disease progression, avoid symptom recurrence, and avoid new interventions.

Doppler echocardiography is the cornerstone in the identification of revascularization failure. Other non-invasive methods, such as the ankle brachial index, computerized tomography, or magnetic resonance, can optimize follow-up in specific situations.


Read also: Secondary Prevention: A Responsibility We Should Not Delegate.


In the case of carotid disease, for example, the (still controversial) recommendation is follow-up with Doppler ultrasound at 1 month, 6 months, and 1 year after endarterectomy or angioplasty. Beyond the initial 2 years after revascularization, in the absence of contralateral disease, we can consider follow-up every 2 or 3 years. However, (at least) annual clinical follow-up is mandatory.

In the case of lower limbs treated with vein grafts (also with a lack of solid evidence), we should conduct a Doppler echocardiography between weeks 4 and 6, and also at 3, 6, 12, and 24 months after the surgery. Clinical surveillance is lifelong, particularly for patients with critical ischemia.

If lower limb revascularization was endovascular, the recommendation is a Doppler echocardiography within the first month and, if results are normal, assessment at 6 and 12 months. If the initial Doppler echocardiography is abnormal, such result warrants closer follow-up and case-by-case assessment. Doppler usefulness one year after the intervention in asymptomatic patients has not been proven and, therefore, cannot be recommended as routine surveillance.


Read also: Benefit of Anticoagulation in the Elderly with Atrial Fibrillation.


All these patients must be assessed globally, considering all their risk factors, systematic exercise, and aggressive medical treatment.

This document also contributes information on how to follow up the rest of the spectrum of patients with peripheral vascular disease.

PIIS1078588419305143

Original title:: Follow-up of Patients After Revascularization for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery.

Reference: Maarit Venermo et al. Eur J Vasc Endovasc Surg (2019) 58, 641e653.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...